Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum: implications for prion propagation and neurotoxicity
Related Experiment Video
Updated: Aug 18, 2026

Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
Yaping Gu1, Susamma Verghese, Ravi Shankar Mishra
1Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Abstract:
Familial prion disorders are believed to result from spontaneous conversion of mutant prion protein (PrPM) to the pathogenic isoform (PrPSc). While most familial cases are heterozygous and thus express the normal (PrPC) and mutant alleles of PrP, the role of PrPC in the pathogenic process is unclear. Plaques from affected cases reveal a heterogeneous picture; in some cases only PrPM is detected, whereas in others both PrPC and PrPM are transformed to PrPSc. To understand if the coaggregation of PrPC is governed by PrP mutations or is a consequence of the cellular compartment of PrPM aggregation, we coexpressed PrPM and PrPC in neuroblastoma cells, the latter tagged with green fluorescent protein (PrPC-GFP) for differentiation. Two PrPM forms (PrP231T, PrP217R/231T) that aggregate spontaneously in the endoplasmic reticulum (ER) were generated for this analysis. We report that PrPC-GFP aggregates when coexpressed with PrP231T or PrP217R/231T, regardless of sequence homology between the interacting forms. Furthermore, intracellular aggregates of PrP231T induce the accumulation of a C-terminal fragment of PrP, most likely derived from a potentially neurotoxic transmembrane form of PrP (CtmPrP) in the ER. These findings have implications for prion pathogenesis in familial prion disorders, especially in cases where transport of PrPM from the ER is blocked by the cellular quality control.
Insights
Mutant prion protein (PrPM) aggregation in familial prion disorders can cause normal prion protein (PrPC) to aggregate, even without sequence similarity. This coaggregation may contribute to neurotoxicity and disease progression.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Familial prion disorders arise from mutations in prion protein (PrP) genes.
- The role of normal prion protein (PrPC) in the pathogenesis of familial prion disorders is not fully understood.
- Prion plaques show varied composition, with some containing only mutant PrP (PrPM) and others both PrPC and PrPM.
Purpose of the Study:
- To investigate whether coaggregation of PrPC with PrPM is driven by specific PrP mutations or by the cellular location of PrPM aggregation.
- To determine if PrPC aggregation depends on sequence homology with PrPM.
Main Methods:
- Coexpression of mutant prion protein (PrPM) and normal prion protein tagged with green fluorescent protein (PrPC-GFP) in neuroblastoma cells.
- Generation of two PrPM variants (PrP231T, PrP217R/231T) known to aggregate spontaneously in the endoplasmic reticulum (ER).
- Analysis of PrPC-GFP aggregation in the presence of these PrPM variants.
Main Results:
- PrPC-GFP aggregated when coexpressed with either PrP231T or PrP217R/231T PrPM.
- PrPC-GFP aggregation occurred irrespective of sequence homology between PrPC and the coexpressed PrPM.
- Intracellular aggregates of PrP231T promoted the accumulation of a C-terminal PrP fragment (CtmPrP) in the ER.
Conclusions:
- PrPC can aggregate with mutant PrPM (PrP231T, PrP217R/231T) in a cellular model of familial prion disorders, independent of sequence homology.
- The aggregation of PrPC is likely influenced by the cellular compartment where PrPM aggregation occurs.
- The accumulation of CtmPrP, a potentially neurotoxic transmembrane form, is linked to PrPM aggregation within the ER, impacting prion pathogenesis.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Unfolded Protein Response
Export of Misfolded Proteins out of the ER
Regulation of the Unfolded Protein Response
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents

